These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 16954108)
21. The influence of agitation sequence and ionic strength on in vitro drug release from hypromellose (E4M and K4M) ER matrices--the use of the USP III apparatus. Asare-Addo K; Kaialy W; Levina M; Rajabi-Siahboomi A; Ghori MU; Supuk E; Laity PR; Conway BR; Nokhodchi A Colloids Surf B Biointerfaces; 2013 Apr; 104():54-60. PubMed ID: 23298588 [TBL] [Abstract][Full Text] [Related]
22. A novel automated alternating current biosusceptometry method to characterization of controlled-release magnetic floating tablets of metronidazole. Ferrari PC; dos Santos Grossklauss DB; Alvarez M; Paixão FC; Andreis U; Crispim AG; de Castro AD; Evangelista RC; de Arruda Miranda JR Drug Dev Ind Pharm; 2014 Aug; 40(8):1123-31. PubMed ID: 23815300 [TBL] [Abstract][Full Text] [Related]
24. Mechanisms of drug release in citrate buffered HPMC matrices. Pygall SR; Kujawinski S; Timmins P; Melia CD Int J Pharm; 2009 Mar; 370(1-2):110-20. PubMed ID: 19100822 [TBL] [Abstract][Full Text] [Related]
25. Use of acryclic and metacrylic acid derivatives as sustained release matrices for theophylline hydrate tablets. Ofoefule SI; Chukwu A Boll Chim Farm; 1999 Nov; 138(10):526-30. PubMed ID: 10765469 [TBL] [Abstract][Full Text] [Related]
26. Preparation and evaluation of gastroretentive floating tablets of Silymarin. Garg R; Gupta GD Chem Pharm Bull (Tokyo); 2009 Jun; 57(6):545-9. PubMed ID: 19483331 [TBL] [Abstract][Full Text] [Related]
27. Structure and hydration properties of hydroxypropyl methylcellulose matrices containing naproxen and naproxen sodium. Katzhendler I; Mäder K; Friedman M Int J Pharm; 2000 May; 200(2):161-79. PubMed ID: 10867246 [TBL] [Abstract][Full Text] [Related]
28. [A comparative analysis of the influence of different types of Carbopol on the release rate of lithium-carbonate from matrix tablets]. Toskić-Radojcić M; Pavlović M; Gazikalović E; Arandjelović A; Kovacević A Vojnosanit Pregl; 2012 Aug; 69(8):675-80. PubMed ID: 22924263 [TBL] [Abstract][Full Text] [Related]
29. Captopril floating and/or bioadhesive tablets: design and release kinetics. Nur AO; Zhang JS Drug Dev Ind Pharm; 2000 Sep; 26(9):965-9. PubMed ID: 10914320 [TBL] [Abstract][Full Text] [Related]
30. Gastric floating matrix tablets: design and optimization using combination of polymers. Prajapati ST; Patel LD; Patel DM Acta Pharm; 2008 Jun; 58(2):221-9. PubMed ID: 18515232 [TBL] [Abstract][Full Text] [Related]
31. The effect of pH and ionic strength of dissolution media on in-vitro release of two model drugs of different solubilities from HPMC matrices. Asare-Addo K; Conway BR; Larhrib H; Levina M; Rajabi-Siahboomi AR; Tetteh J; Boateng J; Nokhodchi A Colloids Surf B Biointerfaces; 2013 Nov; 111():384-91. PubMed ID: 23850747 [TBL] [Abstract][Full Text] [Related]
32. Cellulase as an "active" excipient in prolonged-release HPMC matrices: A novel strategy towards zero-order release kinetics. Palugan L; Filippin I; Cirilli M; Moutaharrik S; Zema L; Cerea M; Maroni A; Foppoli A; Gazzaniga A Int J Pharm; 2021 Sep; 607():121005. PubMed ID: 34391855 [TBL] [Abstract][Full Text] [Related]
33. Nasal mucoadhesive delivery systems of the anti-parkinsonian drug, apomorphine: influence of drug-loading on in vitro and in vivo release in rabbits. Ikechukwu Ugwoke M; Sam E; Van Den Mooter G; Verbeke N; Kinget R Int J Pharm; 1999 Apr; 181(1):125-38. PubMed ID: 10370209 [TBL] [Abstract][Full Text] [Related]
34. Kinetic release of theophylline from hydrophilic swellable matrices. Vargas CI; Ghaly ES Drug Dev Ind Pharm; 1999 Sep; 25(9):1045-50. PubMed ID: 10518245 [TBL] [Abstract][Full Text] [Related]
35. Thermogravimetric investigation of the hydration behaviour of hydrophilic matrices. Segale L; Giovannelli L; Pattarino F; Conti S; Maggi L; Grenier P; Vergnault G J Pharm Sci; 2010 Apr; 99(4):2070-9. PubMed ID: 19780132 [TBL] [Abstract][Full Text] [Related]
36. Effect of antioxidants on captopril floating matrices. Jiménez-Martínez I; Domínguez-Ramírez AM; Villafuerte-Robles L Pharm Dev Technol; 2010 Jun; 15(3):230-40. PubMed ID: 22716463 [TBL] [Abstract][Full Text] [Related]
37. Different HPMC viscosity grades as coating agents for an oral time and/or site-controlled delivery system: an investigation into the mechanisms governing drug release. Zema L; Maroni A; Foppoli A; Palugan L; Sangalli ME; Gazzaniga A J Pharm Sci; 2007 Jun; 96(6):1527-36. PubMed ID: 17094127 [TBL] [Abstract][Full Text] [Related]
38. Optimization of HPMC and carbopol concentrations in non-effervescent floating tablet through factorial design. Acharya S; Patra S; Pani NR Carbohydr Polym; 2014 Feb; 102():360-8. PubMed ID: 24507292 [TBL] [Abstract][Full Text] [Related]
39. Preparation and characterization of a gastric floating dosage form of capecitabine. Taghizadeh Davoudi E; Ibrahim Noordin M; Kadivar A; Kamalidehghan B; Farjam AS; Akbari Javar H Biomed Res Int; 2013; 2013():495319. PubMed ID: 24288681 [TBL] [Abstract][Full Text] [Related]
40. Effect of HPMC and Carbopol on the release and floating properties of Gastric Floating Drug Delivery System using factorial design. Li S; Lin S; Daggy BP; Mirchandani HL; Chien YW Int J Pharm; 2003 Mar; 253(1-2):13-22. PubMed ID: 12593933 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]